Combinations of the PI3K inhibitors LY294002 and wortmannin or the mTOR inhibitor rapamycin with the chemotherapeutics cisplatin or temozolomide lead to a significant 2- to 3-fold increase in melanoma cell apoptosis, but MAPK pathway inhibitors do not significantly increase chemosensitivity [43]. This evidence concerns the gene MTOR and melanoma.